MX9705894A - Extractos de cartilago de tiburon, metodo de produccion y sus usos. - Google Patents
Extractos de cartilago de tiburon, metodo de produccion y sus usos.Info
- Publication number
- MX9705894A MX9705894A MX9705894A MX9705894A MX9705894A MX 9705894 A MX9705894 A MX 9705894A MX 9705894 A MX9705894 A MX 9705894A MX 9705894 A MX9705894 A MX 9705894A MX 9705894 A MX9705894 A MX 9705894A
- Authority
- MX
- Mexico
- Prior art keywords
- extract
- cartilage
- extracts
- homogenate
- shark cartilage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Abstract
La presente invencion se refiere a extractos de cartílago y a un método para producirlos. Los extractos de cartílago de tiburon, que tienen actividades anti-angiogénica, proliferacion directa anti-tumores, anti-inflamatoria y anti-colagenolítica, se han obtenido por un método mejorado. Este método comprende las etapas de obtener un homogenado de cartílago en una solucion acuosa, este homogenado se centrífuga y se fracciona ulteriormente para obtener un extracto total, que tiene moléculas de un peso molecular comprendido entre 0 y 500 KDa. La composicion del extracto líquido se ha investigado por diferentes maneras. El fraccionamiento ulterior de este extracto conduce a la caracterizacion preliminar de algunos de sus componentes activos. Debido a la multiplicidad de actividades biologicas del extracto líquido total, se puede usar para tratar numerosas enfermedades o condiciones, tal como aquéllas que tienen componentes seleccionados del grupo que consiste a la proliferacion de tumores, angiogénesis, inflamacion y colagenolisis. Este extracto no tiene efectos secundarios en las funciones normales del cuerpo. Por lo tanto, este extracto de cartílago de tiburon tiene un valor terapéutico muy promisorio. El método para obtener los extractos de cartílagos es sencillo y eficiente. Los productos, inesperadamente valiosos, obtenidos por este método son, por consiguiente, una indicacion de un método nuevo y no obvio.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/384,555 US5618925A (en) | 1994-04-28 | 1995-02-03 | Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9705894A true MX9705894A (es) | 1998-07-31 |
Family
ID=23517788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9705894A MX9705894A (es) | 1995-02-03 | 1997-08-01 | Extractos de cartilago de tiburon, metodo de produccion y sus usos. |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP0806960B1 (es) |
JP (3) | JPH11502514A (es) |
KR (1) | KR100347880B1 (es) |
CN (1) | CN1138550C (es) |
AT (1) | ATE230272T1 (es) |
AU (1) | AU717978B2 (es) |
BG (1) | BG63801B1 (es) |
BR (1) | BR9510540A (es) |
CA (1) | CA2212010C (es) |
CZ (1) | CZ292627B6 (es) |
DE (1) | DE69529300T2 (es) |
DK (1) | DK0806960T3 (es) |
ES (1) | ES2188672T3 (es) |
FI (1) | FI117376B (es) |
HU (1) | HU222088B1 (es) |
IS (1) | IS1963B (es) |
MX (1) | MX9705894A (es) |
NO (1) | NO318950B1 (es) |
NZ (1) | NZ294553A (es) |
PL (1) | PL188137B1 (es) |
RO (1) | RO117590B1 (es) |
RU (1) | RU2157695C2 (es) |
WO (1) | WO1996023512A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025334A (en) * | 1994-04-28 | 2000-02-15 | Les Laboratoires Aeterna Inc. | Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
US6380366B1 (en) | 1994-04-28 | 2002-04-30 | Les Laboratoires Aeterna Inc. | Shark cartilage extract:process of making, methods of using and compositions thereof |
AU724654B2 (en) * | 1995-04-21 | 2000-09-28 | Aeterna Zentaris Inc. | Extracts of shark cartilage |
AU6639898A (en) | 1997-02-20 | 1998-09-09 | Industrial Research Limited | Angiogenesis inhibitors and activators from shark cartilage |
EP0967987B1 (en) * | 1997-03-11 | 2003-06-04 | Les Laboratoires Aeterna Inc. | Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents |
CA2295519C (en) * | 1997-07-11 | 2008-12-16 | Cv Technologies Inc. | A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
AUPO920597A0 (en) * | 1997-09-16 | 1997-10-09 | Micronized Foods Pty Ltd | Pharmaceutical and/or therapeutic composition or preparation comprising shark cartilage and emu oil |
US20020009501A1 (en) * | 1998-07-23 | 2002-01-24 | Eric Dupont | Preparation of cartilage extracts using organic solvents |
US6168807B1 (en) | 1998-07-23 | 2001-01-02 | Les Laboratoires Aeterna Inc. | Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
CN1064690C (zh) * | 1998-09-10 | 2001-04-18 | 中国人民解放军海军医学研究所 | 鲨鱼软骨血管生成抑制因子及其分离纯化方法 |
US6248341B1 (en) * | 2000-01-14 | 2001-06-19 | Color Access, Inc. | Method of treating topical angiogenesis-related disorders |
EP1276457B1 (en) * | 2000-04-18 | 2011-12-14 | Medestea Internazionale S.p.A. | A composition based on natural extracts useful in the prevention and treatment of cutaneous wrinkles |
BR0114470A (pt) * | 2000-12-20 | 2004-01-13 | Ind Res Ltd | Extrato de carne de tubarão |
WO2004083257A1 (ja) * | 2003-03-20 | 2004-09-30 | Hosokawa Micron Corporation | 軟骨魚類から単離されたプロテオグリカンおよびその製造方法 |
ES2223291B1 (es) * | 2003-08-06 | 2006-03-16 | Bioiberica, S.A. | Nuevo uso terapeutico de condroitin sulfato. |
US7205006B2 (en) * | 2003-09-25 | 2007-04-17 | Prime Pharmaceutical Corporation | Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
CN100377741C (zh) * | 2004-02-23 | 2008-04-02 | 江卫世 | 注射用复方骨肽及其制备工艺 |
US20070248930A1 (en) | 2005-02-17 | 2007-10-25 | Biolux Research Ltd. | Light therapy apparatus and methods |
EP2648651B1 (en) | 2010-12-08 | 2016-11-23 | Biolux Research Limited | Apparatuses useful for regulating bone remodeling or tooth movement using light therapy and a functional appliance |
WO2013133873A2 (en) * | 2011-12-04 | 2013-09-12 | Liu David L | Pharmaceutical compositions of sodium ion and calcium ion and methods for treating cancer, tumor and non-malignancy |
RU2489906C1 (ru) * | 2012-04-18 | 2013-08-20 | Тамара Ивановна Николаева | Биологически активная добавка к пище на основе денатурированного коллагена |
US20130287859A1 (en) * | 2012-04-26 | 2013-10-31 | Lescarden Inc. | Method for treating prupritus with cartilage extract |
DE102012023927A1 (de) * | 2012-12-06 | 2014-06-12 | Heinrich Huber | Heilsalbe gegen Psoriasis, auch als Wundsalbe verwendbar; 50 ml ohne Konservierung |
DE202014011570U1 (de) | 2013-10-22 | 2023-04-04 | Biolux Research Holdings, Inc. | Intraorale Lichttherapiegeräte |
CN106492065A (zh) * | 2016-10-20 | 2017-03-15 | 王凯茜 | 一种治疗风湿热的中药 |
KR102369902B1 (ko) * | 2021-04-23 | 2022-03-02 | 이수한 | 전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4822607A (en) * | 1976-10-29 | 1989-04-18 | Lescarden Ltd. | Anti-tumor agent and method |
US4473551A (en) * | 1982-08-23 | 1984-09-25 | Faxon Pharmaceuticals, Inc. | Anti-inflammatory composition |
US5075112A (en) * | 1990-02-12 | 1991-12-24 | Cartilage Technologies Inc. | Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage |
US5618925A (en) * | 1994-04-28 | 1997-04-08 | Les Laboratories Aeterna Inc. | Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
-
1995
- 1995-10-30 AU AU37388/95A patent/AU717978B2/en not_active Ceased
- 1995-10-30 HU HU9800065A patent/HU222088B1/hu not_active IP Right Cessation
- 1995-10-30 BR BR9510540A patent/BR9510540A/pt not_active Application Discontinuation
- 1995-10-30 DK DK95935309T patent/DK0806960T3/da active
- 1995-10-30 RO RO97-01452A patent/RO117590B1/ro unknown
- 1995-10-30 CZ CZ19972452A patent/CZ292627B6/cs not_active IP Right Cessation
- 1995-10-30 EP EP95935309A patent/EP0806960B1/en not_active Expired - Lifetime
- 1995-10-30 PL PL95321678A patent/PL188137B1/pl not_active IP Right Cessation
- 1995-10-30 KR KR1019970705335A patent/KR100347880B1/ko not_active IP Right Cessation
- 1995-10-30 CA CA002212010A patent/CA2212010C/en not_active Expired - Fee Related
- 1995-10-30 ES ES95935309T patent/ES2188672T3/es not_active Expired - Lifetime
- 1995-10-30 NZ NZ294553A patent/NZ294553A/xx unknown
- 1995-10-30 JP JP8523128A patent/JPH11502514A/ja active Pending
- 1995-10-30 DE DE69529300T patent/DE69529300T2/de not_active Expired - Fee Related
- 1995-10-30 RU RU97114752/14A patent/RU2157695C2/ru not_active IP Right Cessation
- 1995-10-30 WO PCT/CA1995/000617 patent/WO1996023512A1/en active IP Right Grant
- 1995-10-30 AT AT95935309T patent/ATE230272T1/de not_active IP Right Cessation
- 1995-10-30 CN CNB951977598A patent/CN1138550C/zh not_active Expired - Fee Related
-
1997
- 1997-08-01 IS IS4537A patent/IS1963B/is unknown
- 1997-08-01 NO NO19973564A patent/NO318950B1/no unknown
- 1997-08-01 MX MX9705894A patent/MX9705894A/es not_active IP Right Cessation
- 1997-08-01 FI FI973195A patent/FI117376B/fi not_active IP Right Cessation
- 1997-09-01 BG BG101870A patent/BG63801B1/bg unknown
-
2003
- 2003-02-05 JP JP2003028771A patent/JP2003246742A/ja active Pending
-
2006
- 2006-07-31 JP JP2006208897A patent/JP2006290904A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1015683A1 (en) | Extracts of shark cartilage | |
HUT77488A (hu) | Cápaporc- extraktumok, eljárás előállításukra és alkalmazásuk | |
FI964327A (fi) | Hainrusto uutteet joilla on antiangiogeenista aktiivisuutta ja vaikutusta kasvainregressioon; menetelmä niiden valmistamiseksi | |
HK1025507A1 (en) | Soya extract, process for its preparation and pharmaceutical composition. | |
DE59000270D1 (de) | Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen. | |
WO1992000678A3 (fr) | Procede de bioconversion de matieres grasses, notamment pour l'obtention de concentres d'aromes | |
JPS6072821A (ja) | 抗性腺刺激ホルモン物質の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
HC | Change of company name or juridical status |
Owner name: FPINNOVATIONS |
|
MM | Annulment or lapse due to non-payment of fees |